Effect of Melatonin on Sleep Patterns of Resident Trainees During Night Float Shift
Launched by UNIVERSITY OF VIRGINIA · Jan 18, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how melatonin, a natural hormone that helps regulate sleep, can improve sleep quality and quantity for resident physicians working night shifts. Anesthesiology residents often have long and overnight shifts, which can disrupt their sleep patterns and make it hard for them to get enough restful sleep. The goal of this study is to see if taking melatonin can help these doctors sleep better during their night float shifts.
To participate, you need to be a resident in your first to fifth year of training in anesthesiology, general surgery, obstetrics and gynecology, general medicine, or pediatrics at the University of Virginia. You won’t be able to join if you currently use sleep aids, have a diagnosed sleep disorder, or have certain medical conditions like high blood pressure or a history of depression. If you take part in the trial, you can expect to be given melatonin or a placebo (a dummy pill) for comparison, and researchers will monitor how your sleep changes. This study is currently recruiting participants, and it aims to help improve the sleep of doctors who work challenging hours.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Post-Graduate Year 1-5
- • Current enrollment in anesthesiology, general surgery, obstetrics and gynecology, general medicine, or pediatrics residency at the Unversity of Virginia
- Exclusion Criteria:
- • Current use of sleep aids
- • Diagnosed sleep disorder
- • History of a pacemaker or other medical device.
- • pregnant or breast-feeding females
- • Bleeding disorders
- • Depression
- • High blood pressure
- • Seizure disorders
- • History of transplant on immunosuppression therapy.
About University Of Virginia
The University of Virginia (UVA) is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a focus on interdisciplinary collaboration, UVA leverages its extensive resources and expertise in various fields, including medicine, engineering, and public health, to drive cutting-edge studies that address pressing health challenges. The university's clinical trial programs aim to translate scientific discoveries into effective treatments, ensuring the highest standards of ethical practice and participant safety. Through its strong emphasis on community engagement and education, UVA fosters a culture of research that not only contributes to the scientific community but also enhances the well-being of the populations it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charlottesville, Virginia, United States
Charlottesville, Virginia, United States
Patients applied
Trial Officials
Lauren Dunn, MD PHD
Principal Investigator
University of Virginia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials